Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Cancer. 2009 Dec 1;115(23):5534–5540. doi: 10.1002/cncr.24612

Table 2.

Patient Demographics and Predictors of Surgical Resection, Radiotherapy, and Chemotherapy Within 6 Months of Diagnosis

Surgical Resection Radiotherapy Chemotherapy
Characteristic Level No.(%) Total No.(%) Treated Adjusted OR* (95% CI) P No.(%) Treated Adjusted OR* (95% CI) P No.(%) Treated Adjusted OR* (95% CI) P
Histology Astrocytoma 891 (83.5) 478 (53.6) 1 (reference) .06 596 (66.9) 1 (reference) .90 103 (11.6) 1 (reference) .01
Oligodendroglioma 176 (16.5) 101 (57.4) 1.41 (0.99–2.02) 108 (61.4) 0.98 (0.67–1.42) 34 (19.3) 1.86 (1.16–3.01)
Grade Low 180 (16.9) 94 (52.2) 1 (reference) <.0001 102 (56.7) 1 (reference) <.0001 11 (6.1) 1 (reference) .002
Anaplastic 723 (67.8) 425 (58.8) 1.33 (0.94–1.86) 536 (74.1) 2.32 (1.62–3.31) 108 (14.9) 3.25 (1.65–6.38)
Unknown 164 (15.4) 60 (36.6) 0.53 (0.34–0.83) 66 (40.2) 0.57 (0.36–0.90) 18 (11.0) 1.93 (0.85–4.39)
Age at diagnosis, y 65–69 292 (27.4) 172 (58.9) 1 (reference) .0003 222 (76.0) 1 (reference) <.0001 64 (21.9) 1 (reference) <.0001
70–74 288 (27.0) 177 (61.5) 1.09 (0.77–1.53) 196 (68.1) 0.61 (0.41–0.89) 36 (12.5) 0.50 (0.31–0.80)
75–79 280 (26.2) 145 (51.8) 0.75 (0.54–1.06) 178 (63.6) 0.52 (0.35–0.77) 26 (9.3) 0.37 (0.22–0.61)
80–84 132 (12.4) 61 (46.2) 0.62 (0.40–0.95) 72 (54.5) 0.39 (0.24–0.62) 7 (5.3) 0.18 (0.08–0.43)
≥85 75 (7.0) 24 (32.0) 0.36 (0.21–0.62) 36 (48.0) 0.33 (0.19–0.58) <5 0.20 (0.07–0.60)
Gender Male 525 (49.2) 290 (55.2) 1 (reference) .98 343 (65.3) 1 (reference) .06 85 (16.2) 1 (reference) .008
Female 542 (50.8) 289 (53.3) 1.00 (0.76–1.30) 361 (66.6) 1.32 (0.99–1.77) 52 (9.6) 0.58 (0.39–0.87)
Marital status Married 663 (62.1) 376 (56.7) 1 (reference) .74 467 (70.4) 1 (reference) .004 103 (15.5) 1 (reference) .45
Unmarried 362 (33.9) 181 (50.0) 0.89 (0.66–1.19) 215 (59.4) 0.61 (0.45–0.84) 29 (8.0) 0.74 (0.46–1.19)
Unknown 42 (3.9) 22 (52.4) 0.96 (0.50–1.83) 22 (52.4) 0.53 (0.27–1.03) 5 (11.9) 0.95 (0.34–2.66)
Race White 966 (90.5) 530 (54.9) 1 (reference) .32 642 (66.5) 1 (reference) .22 131 (13.6) 1 (reference) .10
Black 35 (3.3) 16 (45.7) 0.64 (0.31–1.32) 21 (60.0) 0.65 (0.30–1.40) <5 0.65 (0.34–2.66)
Other 66 (6.2) 33 (50.0) 0.77 (0.46–1.29) 41 (62.1) 0.67 (0.39–1.16) <5 0.28 (0.18–2.28)
Year of diagnosis 1994–1996 312 (29.2) 163 (52.2) 1 (reference) .63 212 (67.9) 1 (reference) .29 42 (13.5) 1 (reference) .46
1997–1999 283 (26.5) 162 (57.2) 1.17 (0.84–1.64) 200 (70.7) 1.00 (0.68–1.45) 44 (15.5) 1.10 (0.67–1.79)
2000–2002 472 (44.2) 254 (53.8) 1.12 (0.83–1.51) 292 (61.9) 0.80 (0.58–1.11) 51 (10.8) 0.83 (0.52–1.31)
Census tract Poverty level <10% 674 (63.2) 363 (53.9) 1 (reference) .33 442 (65.6) 1 (reference) .49 87 (12.9) 1 (reference) .004
≥10% 359 (33.7) 195 (54.3) 1.15 (0.87–1.53) 240 (66.9) 1.20 (0.88–1.64) 39 (10.9) 0.95 (0.61–1.48)
Unknown 34 (3.2) 21 (61.8) 1.65 (0.74–3.67) 22 (64.7) 1.16 (0.50–2.66) 11 (32.4) 4.73 (1.86–12.0)
Urban/rural Big metropolitan or metropolitan 913 (85.6) 502 (55.0) 1 (reference) .06 602 (65.9) 1 (reference) .37 119 (13.0) 1 (reference) .28
Urban, less urban, or rural 154 (14.4) 77 (50.0) 0.70 (0.49–1.01) 102 (66.2) 0.83 (0.56–1.24) 18 (11.7) 0.73 (0.41–1.30)
No. of prior cancers 0 915 (85.8) 497 (54.3) 1 (reference) .82 607 (66.3) 1 (reference) .72 111 (12.1) 1 (reference) .15
1 129 (12.1) 69 (53.5) 0.88 (0.58–1.32) 83 (64.3) 0.89 (0.57–1.39) 24 (18.6) 1.26 (0.71–2.24)
≥2 23 (2.2) 13 (56.5) 0.94 (0.37–2.36) 14 (60.9) 0.71 (0.27–1.86) <5 0.26 (0.05–1.33)
Comorbidity index 0 790 (74.0) 442 (55.9) 1 (reference) .17 540 (68.4) 1 (reference) .41 113 (14.3) 1 (reference) .52
1 177 (16.6) 94 (53.1) 0.97 (0.68–1.37) 107 (60.5) 0.82 (0.57–1.18) 16 (9.0) 0.74 (0.41–1.33)
≥2 100 (9.4) 43 (43.0) 0.66 (0.42–1.02) 57 (57.0) 0.79 (0.50–1.25) 8 (8.0) 0.78 (0.35–1.72)

OR indicates odds ratio; 95% CI, 95% confidence interval.

*

Based on a multivariate logistic regression model in which each variable was adjusted for all others.